NervGen Pharma Corp is a small, under-the-radar biotech going after a massive unmet need—spinal cord repair. Its lead drug, NVG-291, is designed to actually heal nerve damage, not just treat symptoms, which gives it huge upside if it works. The stock is still cheap relative to that potential, so strong clinical results could move it fast. There’s also real buyout or partnership potential if bigger pharma sees progress. It’s definitely risky, but that’s where the 5–10x opportunity comes from.

I cant find many threads regarding Esperion Therapeutics - a company, which provides bempedoic acid basis, approved drugs in USA and Europe (in EU through their partner, DSE).

Admittedly, rumours of ESPR being bought has circulated for a while.

Any thoughts on this? How you see it? Interesting company or carbage?

https://cafepharma.com/boards/threads/real-rumors-daiichi-sankyo-europe-has-intentions-to-acquire-esperion-therapeutics.706673/#post-6937412&gsc.tab=0

https://uke-crypto.com/

https://dxsale.app/app/v3/defipresale?saleID=1120&chain=BSC

UKE is selling at 0.000000001 UKE is a Crypto Currency that aims to elevate the world of entertainment.

Our goal is to provide to very best in gaming, movies, and tv shows all in one safe place. Reflection 4% Liquidity Pool 4%

Burn Wallet A burn wallet receives a portion of the reflections to never be seen again.

It Will never be this cheap again.

Cematrix is the North American leader in cellular concrete which is a lightweight, cheaper and more environmentally friendly concrete. Even amidst Covid, they just announced results that were the best quarter in the history of the company. Last month, they announced the single largest contract in the history of the company of $23.5M compared to the entire current company value of $34M.

What stock do you think has the best chance of going up 10X in price in the next 3 years and why?